SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Tushuizen ME,Diamant M,Sturk A,Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: Friend or foe? Arterioscler Thromb Vasc Biol 2011; 31: 49.
  • 2
    Amabile N,Rautou P-E,Tedgui A,Boulanger CM. Microparticles: Key protagonists in cardiovascular disorders. Semin Thromb Hemost 2010; 36: 907916.
  • 3
    Pankoui Mfonkeu JB,Gouado I,Fotso Kuaté H,Zambou O,Amvam Zollo PH,Grau GER,Combes V. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 2010; 5: e13415.
  • 4
    Rak J. Microparticles in cancer. Semin Thromb Hemost 2010; 36: 888906.
  • 5
    Tissot J-D,Rubin O,Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010; 17: 571577.
  • 6
    Jy W,Ricci M,Shariatmadar S,Gomez-Marin O,Horstman LH,Ahn YS. Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011; 51: 886893.
  • 7
    Willekens FLA,Werre JM,Groenen-Döpp YAM,Roerdinkholder-Stoelwinder B,de Pauw B,Bosman GJCGM. Erythrocyte vesiculation: A self-protective mechanism? Br J Haematol 2008; 141: 549556.
  • 8
    Donadee C,Raat NJH,Kanias T,Tejero J,Lee JS,Kelley EE,Zhao X,Liu C,Reynolds H,Azarov I, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465476.
  • 9
    Gao C,Xie R,Yu C,Wang Q,Shi F,Yao C,Xie R,Zhou J,Gilbert GE,Shi J. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 2012; 107.
  • 10
    Frey B,Gaipl U. The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol 2011; 33: 497516.
  • 11
    Lacroix R,Robert S,Poncelet P,Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010; 36: 807818.
  • 12
    Ayers L,Kohler M,Harrison P,Sargent I,Dragovic R,Schaap M,Nieuwland R,Brooks SA,Ferry B. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res 2011; 127: 370377.
  • 13
    Erdbruegger. Detection of circulating microparticles by flow cytometry: Influence of centrifugation, filtration of buffer, and freezing. Vasc Health Risk Manag 2010; 11251133.
  • 14
    Morel O,Jesel L,Freyssinet J-M,Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 1526.
  • 15
    Meers P,Mealy T. Calcium-dependent annexin V binding to phospholipids: Stoichiometry, specificity, and the role of negative charge. Biochemistry 1993; 32: 1171111721.
  • 16
    Amabile N,Guérin AP,Leroyer A,Mallat Z,Nguyen C,Boddaert J,London GM,Tedgui A,Boulanger CM. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 33813388.
  • 17
    Trappenburg MC,Van Schilfgaarde M,Frerichs FCP,Spronk HMH,Ten Cate H,De Fijter CWH,Terpstra WE,Leyte A. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrol Dial Transplant 2012; 27: 14461453.
  • 18
    Al-Massarani G,Vacher-Coponat H,Paul P,Arnaud L,Loundou A,Robert S,Moal V,Berland Y,Dignat-George F,Camoin-Jau L, et al. Kidney transplantation decreases the level and procoagulant activity of circulating microparticles. Am J Transplant 2009; 9: 550557.
  • 19
    Daniel L,Fakhouri F,Joly D,Mouthon L,Nusbaum P,Grunfeld J-P,Schifferli J,Guillevin L,Lesavre P,Halbwachs-Mecarelli L. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006; 69: 14161423.
  • 20
    van den Akker J,van Weert A,Afink G,Bakker E,van der Pol E,Böing A,Nieuwland R,VanBavel E. Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids 2012; 42: 961973.
  • 21
    Amabile N,Guérin AP,Tedgui A,Boulanger CM,London GM. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: A pilot study. Nephrol Dial Transplant 2012; 27: 18731880.
  • 22
    Lu X,Leng Y. Theoretical analysis of calcium phosphate precipitation in simulated body fluid. Biomaterials 2005; 26: 10971108.
  • 23
    Ewence AE,Bootman M,Roderick HL,Skepper JN,McCarthy G,Epple M,Neumann M,Shanahan CM,Proudfoot D. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells a potential mechanism in atherosclerotic plaque destabilization. Circ Res 2008; 103: e28e34.
  • 24
    Furie B,Zwicker J,LaRocca T,Kos C,Bauer B,Furie B. Tissue factor-bearing microparticles and cancer-associated thrombosis. Haemotologica Rep 2005; 1: 58.
  • 25
    Lacroix R,Robert S,Poncelet P,Kasthuri RS,Key NS,Dignat-George F. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: Results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 25712574.
  • 26
    Vorauer-Uhl K,Wagner A,Borth N,Katinger H. Determination of liposome size distribution by flow cytometry. Cytometry 2000; 39: 166171.
  • 27
    Graves HCB. The effect of surface charge on non-specific binding of rabbit immunoglobulin G in solid-phase immunoassays. J Immunol Methods 1988; 111: 157166.
  • 28
    Blankenberg F,Narula J,Strauss HW. In vivo detection of apoptotic cell death: A necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure. J Nucl Cardiol 1999; 6: 531539.
  • 29
    Tait JF,Gibson D. Phospholipid binding of annexin V: Effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 1992; 298: 187191.
  • 30
    Peracchia C,Peracchia LL. Gap junction dynamics: Reversible effects of divalent cations. J Cell Biol 1980; 87: 708718.
  • 31
    Shi J,Shi Y,Waehrens LN,Rasmussen JT,Heegaard CW,Gilbert GE. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry Part A 2006; 69A: 11931201.
  • 32
    Connor DE,Exner T,Ma DDF,Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 10441052.
  • 33
    Balasubramanian K,Bevers EM,Willems GM,Schroit AJ. Binding of annexin V to membrane products of lipid peroxidation. Biochemistry 2001; 40: 86728676.
  • 34
    Shi J,Pipe SW,Rasmussen JT,Heegaard CW,Gilbert GE. Lactadherin blocks thrombosis and hemostasis in vivo: Correlation with platelet phosphatidylserine exposure. J Thromb Haemost 2008; 6: 11671174.
  • 35
    Yuana Y,Bertina RM,Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2011; 105: 396408.
  • 36
    Shi J,Heegaard CW,Rasmussen JT,Gilbert GE. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta 2004; 1667: 8290.
  • 37
    Larson MC,Woodliff JE,Hillery CA,Kearl TJ,Zhao M. Phosphatidylethanolamine is exposed at the surface of microparticles. Biochim Biophys Acta 2012; 1821: 15011507.
  • 38
    Daniel L,Dou L,Berland Y,Lesavre P,Mecarelli-Halbwachs L,Dignat-George F. Circulating microparticles in renal diseases. Nephrol Dial Transplant 2008; 23: 21292132.
  • 39
    Shobeiri N,Adams MA,Holden RM. Vascular calcification in animal models of CKD: A review. Am J Nephrol 2010; 31: 471481.